The Woodcliff Lake-based company boasts a robust pipeline and just added two commercialized products through its acquisition of Acacia Pharma. In short, Eagle is ready to soar.
Read More »Author Archives: Jeffrey Kanige
NJBIZ Conversations: Leonard Mazur
Citius Pharmaceuticals Executive Chairman Leonard Mazur discusses the company's pipeline and the business climate for the industry in the state.
Read More »NJBIZ Conversations: Mike Affuso
The incoming president and CEO of the New Jersey Bankers Association talks about how the organization will meet the challenges wrought by economic and geopolitical turmoil.
Read More »Incoming bankers association CEO ready to meet challenges
Michael Affuso brings a wealth of political know-how to his work at the NJBA, where he'll take over as president and CEO, replacing John McWeeney, who is retiring.
Read More »NJBIZ Conversations: Warren Geller
The CEO of Englewood Health discusses the implications of the court ruling blocking its deal with Hackensack Meridian and how the hospital and health care system will continue to serve an expanding number of communities, among other subjects.
Read More »NJBIZ Conversations: Chris Beddard
The head of core molecular diagnostics and women's health and cancer at BD integrated diagnostic solutions discusses the company's new cervical cancer screening system and the importance of early detection.
Read More »How do states stack up when it comes to gender pay equity?
A new study by research firm business.org ranks New Jersey smack in the middle of states on the issue of pay equity between men and women. How do our neighbors stack up?
Read More »BD’s new screening aims to keep cervical cancer at bay
BD’s Chris Beddard explains the advantages of the company’s new screening mechanism for cervical cancer and why it’s time to pay attention again.
Read More »Eagle Pharmaceuticals to acquire UK-based Acacia Pharma
The target develops products designed to improve care for patients undergoing significant treatments such as surgery, other invasive procedures or chemotherapy.
Read More »NJBIZ Conversations: Chris Maher
The CEO of OceanFirst Financial returns to discuss the outlook for inflation, hiring and the industries showing strength amid the turmoil.
Read More »Presenting the 2022 NJBIZ Health Care Power 50
Meet the men and women leading the industry that keeps New Jerseyans strong, active and full of life.
Read More »Appeals court upholds rejection of Hackensack Meridian-Englewood merger
In a 34-page ruling, the panel found that the FTC was justified in seeking to stop the deal. The court noted that an expert advising the agency estimated that the hospitals would have been able to increase prices by $31 million after the combination.
Read More »